Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma
Clinical trial NCT00513604 · COMPLETED
Trial details
- NCT number
- NCT00513604
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2012-11-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.